Inherited blistering skin diseases: underlying molecular mechanisms and emerging therapies

References

• Simpson CL, Patel DM, Green KJ. Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis. Nat Rev Mol Cell Biol. 2011;12:565–80.
   PubMed Web of Science ®Google Scholar
• Elias PM. Skin barrier function. Curr Allergy Asthma Rep. 2008;8: 299–305.
   PubMed Web of Science ®Google Scholar
• Tsuruta D, Hashimoto T, Hamill KJ, Jones JC. Hemidesmosomes and focal contact proteins: functions and cross-talk in keratinocytes, bullous diseases and wound healing. J Dermatol Sci. 2011; 62:1–7.
   Google Scholar
• Green KJ, Getsios S, Troyanovsky S, Godsel LM. Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb Perspect Biol. 2010;2:a000125.
   PubMed Web of Science ®Google Scholar
• Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, et al. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008;58: 931–50.
   PubMed Web of Science ®Google Scholar
• Bruckner-Tuderman L, McGrath JA, Robinson EC, Uitto J. Progress in epidermolysis bullosa research: Summary of DEBRA International Research Conference 2012. J Invest Dermatol. 2013;133:2121–6.
   PubMedGoogle Scholar
• Pearson RW. Studies on the pathogenesis of epidermolysis bullosa. J Invest Dermatol. 1962;39:551–75.
   PubMed Web of Science ®Google Scholar
• Kim S, Coulombe PA. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev. 2007;21:1581–97.
   PubMed Web of Science ®Google Scholar
• Celli A, Sanchez S, Behne M, Hazlett T, Gratton E, Mauro T. The epidermal Ca(2+) gradient: measurement using the phasor representation of fluorescent lifetime imaging. Biophys J. 2010;98:911–21.
   PubMed Web of Science ®Google Scholar
• Coulombe PA, Lee CH. Defining keratin protein function in skin epithelia: epidermolysis bullosa simplex and its aftermath. J Invest Dermatol. 2012;132:763–75.
   PubMed Web of Science ®Google Scholar
• McLean WH, Moore CB. Keratin disorders: from gene to therapy. Hum Mol Genet. 2011;20:R189–97.
   Web of Science ®Google Scholar
• Sprecher E. Epidermolysis bullosa simplex. Dermatol Clin. 2010;28: 23–32.
   PubMedGoogle Scholar
• Rezniczek GA, Walko G, Wiche G. Plectin gene defects lead to various forms of epidermolysis bullosa simplex. Dermatol Clin. 2010;28: 33–41.
   PubMedGoogle Scholar
• Winter L, Wiche G. The many faces of plectin and plectinopathies: pathology and mechanisms. Acta Neuropathol. 2013;125:77–93.
   PubMed Web of Science ®Google Scholar
• McLean WH, Pulkkinen L, Smith FJ, Rugg EL, Lane EB, Bullrich F, et al. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev. 1996; 10:1724–35.
   PubMedGoogle Scholar
• Smith FJ, Eady RA, Leigh IM, McMillan JR, Rugg EL, Kelsell DP, et al. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet. 1996;13:450–7.
   PubMed Web of Science ®Google Scholar
• Charlesworth A, Chiaverini C, Chevrant-Breton J, DelRio M, Diociaiuti A, Dupuis RP, et al. Epidermolysis bullosa simplex with PLEC mutations: new phenotypes and new mutations. Br J Dermatol. 2013;168:808–14.
   PubMedGoogle Scholar
• Bolling MC, Jongbloed JD, Boven LG, Diercks GF, Smith FJ, McLean WH, et al. Plectin mutations underlie epidermolysis bullosa simplex in 8% of patients. J Invest Dermatol. 2014;134:273–6.
   PubMed Web of Science ®Google Scholar
• Kligys KR, Wu Y, Hopkinson SB, Kaur S, Platanias LC, Jones JC.α6β4 Integrin, a master regulator of expression of integrins in human keratinocytes. J Biol Chem. 2012;287:17975–84.
   PubMedGoogle Scholar
• Margadant C, Charafeddine RA, Sonnenberg A. Unique and redundant functions of integrins in the epidermis. FASEB J. 2010;24:4133–52.
   PubMed Web of Science ®Google Scholar
• Chung HJ, Uitto J. Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa. Dermatol Clin. 2010;28: 93–105.
   PubMed Web of Science ®Google Scholar
• Ashton GH, Sorelli P, Mellerio JE, Keane FM, Eady RA, McGrath JA. Alpha 6 beta 4 integrin abnormalities in junctional epidermolysis bullosa with pyloric atresia. Br J Dermatol. 2001;144:408–14.
   PubMed Web of Science ®Google Scholar
• Inoue M, Tamai K, Shimizu H, Owaribe K, Nakama T, Hashimoto T, et al. A homozygous missense mutation in the cytoplasmic tail of beta4 integrin, G931D, that disrupts hemidesmosome assembly and underlies non-Herlitz junctional epidermolysis bullosa without pyloric atresia?J Invest Dermatol. 2000;114:1061–4.
   PubMed Web of Science ®Google Scholar
• Sugawara K, Tsuruta D, Ishii M, Jones JC, Kobayashi H. Laminin-332 and -511 in skin. Exp Dermatol. 2008;17:473–80.
   Google Scholar
• Kiritsi D, Has C, Bruckner-Tuderman L. Laminin 332 in junctional epidermolysis bullosa. Cell Adh Migr. 2013;7:135–41.
   PubMed Web of Science ®Google Scholar
• Laimer M, Lanschuetzer CM, Diem A, Bauer JW. Herlitz junctional epidermolysis bullosa. Dermatol Clin. 2010;28:55–60.
   Google Scholar
• Yancey KB, Hintner H. Non-Herlitz junctional epidermolysis bullosa. Dermatol Clin. 2010;28:67–77.
   PubMed Web of Science ®Google Scholar
• McLean WH, Irvine AD, Hamill KJ, Whittock NV, Coleman-Campbell CM, Mellerio JE, et al. An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome. Hum Mol Genet. 2003;12: 2395–409.
   PubMed Web of Science ®Google Scholar
• Powell AM, Sakuma-Oyama Y, Oyama N, Black MM. Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex. Clin Exp Dermatol. 2005;30: 682–7.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381: 320–32.
   PubMed Web of Science ®Google Scholar
• McGrath JA, Gatalica B, Christiano AM, Li K, Owaribe K, McMillan JR, et al. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet. 1995;11:83–6.
   PubMed Web of Science ®Google Scholar
• McGrath JA, Gatalica B, Li K, Dunnill MG, McMillan JR, Christiano AM, et al. Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol. 1996;148:1787–96.
   PubMedGoogle Scholar
• Almaani N, Liu L, Dopping-Hepenstal PJ, Lovell PA, Lai-Cheong JE, Graham RM, et al. Autosomal dominant junctional epidermolysis bullosa. Br J Dermatol. 2009;160:1094–7.
   PubMed Web of Science ®Google Scholar
• Burgeson RE, Lunstrum GP, Rokosova B, Rimberg CS, Rosenbaum LM, Keene DR. The structure and function of type VII collagen. Ann N Y Acad Sci. 1990;580:32–43.
   PubMed Web of Science ®Google Scholar
• Tidman MJ, Eady RA. Ultrastructural morphometry of normal human dermal-epidermal junction. The influence of age, sex, and body region on laminar and nonlaminar components. J Invest Dermatol. 1984;83: 448–53.
   Google Scholar
• Christiano AM, Suga Y, Greenspan DS, Ogawa H, Uitto J. Premature termination codons on both alleles of the type VII collagen gene (COL7A1) in three brothers with recessive dystrophic epidermolysis bullosa. J Clin Invest. 1995;95:1328–34.
   PubMedGoogle Scholar
• Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61:367–84.
   PubMedGoogle Scholar
• Christiano AM, McGrath JA, Tan KC, Uitto J. Glycine substitutions in the triple-helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance. Am J Hum Genet. 1996;58:671–81.
   PubMed Web of Science ®Google Scholar
• Christiano AM, Ryynanen M, Uitto J. Dominant dystrophic epidermolysis bullosa: identification of a Gly--> Ser substitution in the triple-helical domain of type VII collagen. Proc Natl Acad Sci U S A. 1994;91:3549–53.
   PubMedGoogle Scholar
• Meves A, Stremmel C, Gottschalk K, Fassler R. The Kindlin protein family: new members to the club of focal adhesion proteins. Trends Cell Biol. 2009;19:504–13.
   PubMed Web of Science ®Google Scholar
• Lai-Cheong JE, Parsons M, McGrath JA. The role of kindlins in cell biology and relevance to human disease. Int J Biochem Cell Biol. 2010;42:595–603.
   PubMed Web of Science ®Google Scholar
• Jobard F, Bouadjar B, Caux F, Hadj-Rabia S, Has C, Matsuda F, et al. Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome. Hum Mol Genet. 2003;12:925–35.
   PubMed Web of Science ®Google Scholar
• Siegel DH, Ashton GH, Penagos HG, Lee JV, Feiler HS, Wilhelmsen KC, et al. Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet. 2003;73: 174–87.
   PubMed Web of Science ®Google Scholar
• Lai-Cheong JE, Tanaka A, Hawche G, Emanuel P, Maari C, Taskesen M, et al. Kindler syndrome: a focal adhesion genodermatosis. Br J Dermatol. 2009;160:233–42.
   PubMed Web of Science ®Google Scholar
• Kowalczyk AP, Green KJ. Structure, function, and regulation of desmosomes. Prog Mol Biol Transl Sci. 2013;116:95–118.
   PubMed Web of Science ®Google Scholar
• Nekrasova O, Green KJ. Desmosome assembly and dynamics. Trends Cell Biol. 2013;23:537–46.
   PubMed Web of Science ®Google Scholar
• McGrath JA, McMillan JR, Shemanko CS, Runswick SK, Leigh IM, Lane EB, et al. Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat Genet. 1997;17:240–4.
   PubMed Web of Science ®Google Scholar
• South AP, Wan H, Stone MG, Dopping-Hepenstal PJ, Purkis PE, Marshall JF, et al. Lack of plakophilin 1 increases keratinocyte migration and reduces desmosome stability. J Cell Sci. 2003;116:3303–14.
   PubMed Web of Science ®Google Scholar
• Hatzfeld M. Plakophilins: multifunctional proteins or just regulators of desmosomal adhesion?Biochim Biophys Acta. 2007;1773:69–77.
   PubMed Web of Science ®Google Scholar
• Wolf A, Hatzfeld M. A role of plakophilins in the regulation of translation. Cell Cycle. 2010;9:2973–8.
   PubMed Web of Science ®Google Scholar
• Garrod D, Chidgey M. Desmosome structure, composition and function. Biochim Biophys Acta. 2008;1778:572–87.
   PubMed Web of Science ®Google Scholar
• Armstrong DK, McKenna KE, Purkis PE, Green KJ, Eady RA, Leigh IM, et al. Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. Hum Mol Genet. 1999;8: 143–8.
   PubMed Web of Science ®Google Scholar
• Rizzo S, Pilichou K, Thiene G, Basso C. The changing spectrum of arrhythmogenic (right ventricular) cardiomyopathy. Cell Tissue Res. 2012;348:319–23.
   PubMed Web of Science ®Google Scholar
• Petrof G, Mellerio JE, McGrath JA. Desmosomal genodermatoses. Br J Dermatol. 2012;166:36–45.
   PubMed Web of Science ®Google Scholar
• Jonkman MF, Pasmooij AM, Pasmans SG, van den Berg MP, Ter Horst HJ, Timmer A, et al. Loss of desmoplakin tail causes lethal acantholytic epidermolysis bullosa. Am J Hum Genet. 2005;77:653–60.
   PubMed Web of Science ®Google Scholar
• Hobbs RP, Han SY, van der Zwaag PA, Bolling MC, Jongbloed JD, Jonkman MF, et al. Insights from a desmoplakin mutation identified in lethal acantholytic epidermolysis bullosa. J Invest Dermatol. 2010;130:2680–3.
   PubMed Web of Science ®Google Scholar
• Groves RW, Liu L, Dopping-Hepenstal PJ, Markus HS, Lovell PA, Ozoemena L, et al. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol. 2010;130:1551–7.
   PubMedGoogle Scholar
• Liu L, Dopping-Hepenstal PJ, Lovell PA, Michael M, Horn H, Fong K, et al. Autosomal recessive epidermolysis bullosa simplex due to loss of BPAG1-e expression. J Invest Dermatol. 2012;132:742–4.
   PubMedGoogle Scholar
• Michael M, Begum R, Fong K, Pourreyrone C, South AP, McGrath JA, et al. BPAG1-e restricts keratinocyte migration through control of adhesion stability. J Invest Dermatol.2013 Sep 11 [Epub ahead of print].
   Google Scholar
• Hodivala-Dilke KM, DiPersio CM, Kreidberg JA, Hynes RO. Novel roles for alpha3beta1 integrin as a regulator of cytoskeletal assembly and as a trans-dominant inhibitor of integrin receptor function in mouse keratinocytes. J Cell Biol. 1998;142:1357–69.
   PubMedGoogle Scholar
• Has C, Sparta G, Kiritsi D, Weibel L, Moeller A, Vega-Warner V, et al. Integrin alpha3 mutations with kidney, lung, and skin disease. N Engl J Med. 2012;366:1508–14.
   PubMed Web of Science ®Google Scholar
• Yin T, Green KJ. Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol. 2004;15:665–77.
   PubMed Web of Science ®Google Scholar
• McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet. 2000;355:2119–24.
   PubMed Web of Science ®Google Scholar
• Azaouagh A, Churzidse S, Konorza T, Erbel R. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update. Clin Res Cardiol. 2011;100:383–94.
   PubMed Web of Science ®Google Scholar
• Li D, Liu Y, Maruyama M, Zhu W, Chen H, Zhang W, et al. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy. Hum Mol Genet. 2011;20:4582–96.
   PubMed Web of Science ®Google Scholar
• Winik BC, Asial RA, McGrath JA, South AP, Boente MC. Acantholytic ectodermal dysplasia: clinicopathological study of a new desmosomal disorder. Br J Dermatol. 2009;160:868–74.
   PubMedGoogle Scholar
• Cabral RM, Liu L, Hogan C, Dopping-Hepenstal PJ, Winik BC, Asial RA, et al. Homozygous mutations in the 5’ region of the JUP gene result in cutaneous disease but normal heart development in children. J Invest Dermatol. 2010;130:1543–50.
   PubMed Web of Science ®Google Scholar
• Pigors M, Kiritsi D, Krumpelmann S, Wagner N, He Y, Podda M, et al. Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity. Hum Mol Genet. 2011;20:1811–19.
   PubMed Web of Science ®Google Scholar
• McGrath JA, Stone KL, Begum R, Simpson MA, Dopping-Hepenstal PJ, Liu L, et al. Germline mutation in EXPH5 implicates the Rab27B effector protein Slac2-b in inherited skin fragility. Am J Hum Genet. 2012;91:1115–21.
   PubMedGoogle Scholar
• Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009;10:513–25.
   PubMed Web of Science ®Google Scholar
• Pigors M, Schwieger-Briel A, Leppert J, Kiritsi D, Kohlhase J, Bruckner-Tuderman L, et al. Molecular heterogeneity of epidermolysis bullosa simplex: contribution of EXPH5 mutations. J Invest Dermatol.2013 Sep 4 [Epub ahead of print].
   Google Scholar
• Liu L, Mellerio JE, Martinez AE, McMillan JR, Aristodemou S, Parsons M, et al. Mutations in EXPH5 result in autosomal recessive skin fragility. Br J Dermatol. 2014;170:204–7.
   PubMedGoogle Scholar
• Cassidy AJ, van Steensel MA, Steijlen PM, van Geel M, van der Velden J, Morley SM, et al. A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activity and causes acral peeling skin syndrome. Am J Hum Genet. 2005;77:909–17.
   PubMed Web of Science ®Google Scholar
• Pietroni V, Di Giorgi S, Paradisi A, Ahvazi B, Candi E, Melino G. Inactive and highly active, proteolytically processed transglutaminase-5 in epithelial cells. J Invest Dermatol. 2008;128:2760–6.
   PubMedGoogle Scholar
• Kharfi M, El Fekih N, Ammar D, Jaafoura H, Schwonbeck S, van Steensel MA, et al. A missense mutation in TGM5 causes acral peeling skin syndrome in a Tunisian family. J Invest Dermatol. 2009;129:2512–15.
   PubMedGoogle Scholar
• Kiritsi D, Cosgarea I, Franzke CW, Schumann H, Oji V, Kohlhase J, et al. Acral peeling skin syndrome with TGM5 gene mutations may resemble epidermolysis bullosa simplex in young individuals. J Invest Dermatol. 2010;130:1741–6.
   PubMedGoogle Scholar
• van der Velden JJ, Jonkman MF, McLean WH, Hamm H, Steijlen PM, van Steensel MA, et al. A recurrent mutation in the TGM5 gene in European patients with acral peeling skin syndrome. J Dermatol Sci. 2012;65:74–6.
   PubMedGoogle Scholar
• Chen J, Den Z, Koch PJ. Loss of desmocollin 3 in mice leads to epidermal blistering. J Cell Sci. 2008;121:2844–9.
   PubMed Web of Science ®Google Scholar
• Ayub M, Basit S, Jelani M, Ur Rehman F, Iqbal M, Yasinzai, et al. A homozygous nonsense mutation in the human desmocollin-3 (DSC3) gene underlies hereditary hypotrichosis and recurrent skin vesicles. Am J Hum genet. 2009;85:515–20.
   PubMed Web of Science ®Google Scholar
• Hammers CM, Stanley JR. Desmoglein-1, differentiation, and disease. J Clin Invest. 2013;123:1419–22.
   PubMedGoogle Scholar
• Amagai M, Stanley JR. Desmoglein as a target in skin disease and beyond. J Invest Dermatol. 2012;132:776–84.
   PubMed Web of Science ®Google Scholar
• Rickman L, Simrak D, Stevens HP, Hunt DM, King IA, Bryant SP, et al. N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum Mol Genet. 1999;8:971–6.
   PubMed Web of Science ®Google Scholar
• Zamiri M, Smith FJ, Campbell LE, Tetley L, Eady RA, Hodgins MB, et al. Mutation in DSG1 causing autosomal dominant striate palmoplantar keratoderma. Br J Dermatol. 2009;161:692–4.
   PubMedGoogle Scholar
• Samuelov L, Sarig O, Harmon RM, Rapaport D, Ishida-Yamamoto A, Isakov O, et al. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet. 2013;45:1244–8.
   PubMed Web of Science ®Google Scholar
• Jonca N, Guerrin M, Hadjiolova K, Caubet C, Gallinaro H, Simon M, et al. Corneodesmosin, a component of epidermal corneocyte desmosomes, displays homophilic adhesive properties. J Biol Chem. 2002; 277:5024–9.
   PubMedGoogle Scholar
• Simon M, Jonca N, Guerrin M, Haftek M, Bernard D, Caubet C, et al. Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem. 2001;276:20292–9.
   PubMed Web of Science ®Google Scholar
• Levy-Nissenbaum E, Betz RC, Frydman M, Simon M, Lahat H, Bakhan T, et al. Hypotrichosis simplex of the scalp is associated with nonsense mutations in CDSN encoding corneodesmosin. Nat Genet. 2003;34:151–3.
   PubMedGoogle Scholar
• Oji V, Eckl KM, Aufenvenne K, Natebus M, Tarinski T, Ackermann K, et al. Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease. Am J Hum Genet. 2010;87:274–81.
   PubMed Web of Science ®Google Scholar
• Sterk LM, Geuijen CA, Oomen LC, Calafat J, Janssen H, Sonnenberg A. The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes. J Cell Biol. 2000;149:969–82.
   PubMed Web of Science ®Google Scholar
• Kagan A, Feld S, Chemke J, Bar-Khayim Y. Occurrence of hereditary nephritis, pretibial epidermolysis bullosa and beta-thalassemia minor in two siblings with end-stage renal disease. Nephron. 1988;49:331–2.
   PubMed Web of Science ®Google Scholar
• Karamatic Crew V, Burton N, Kagan A, Green CA, Levene C, Flinter F, et al. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood. 2004;104: 2217–23.
   PubMed Web of Science ®Google Scholar
• Arin MJ, Oji V, Emmert S, Hausser I, Traupe H, Krieg T, et al. Expanding the keratin mutation database: novel and recurrent mutations and genotype-phenotype correlations in 28 patients with epidermolytic ichthyosis. Br J Dermatol. 2011;164:442–7.
   PubMedGoogle Scholar
• Oji V, Tadini G, Akiyama M, Blanchet Bardon C, Bodemer C, Bourrat E, et al. Revised nomenclature and classification of Soreze 2009. inherited ichthyoses: results of the First Ichthyosis Consensus Conference in J Am Acad Dermatol. 2010;63:607–41.
   Google Scholar
• Varki R, Sadowski S, Uitto J, Pfendner E. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet. 2007;44:181–92.
   PubMed Web of Science ®Google Scholar
• Fassihi H, Eady RA, Mellerio JE, Ashton GH, Dopping-Hepenstal PJ, Denyer JE, et al. Prenatal diagnosis for severe inherited skin disorders: 25 years’ experience. Br J Dermatol. 2006;154:106–13.
   PubMedGoogle Scholar
• Fassihi H, Liu L, Renwick PJ, Braude PR, McGrath JA. Development and successful clinical application of preimplantation genetic haplotyping for Herlitz junctional epidermolysis bullosa. Br J Dermatol. 2010;162:1330–6.
   PubMed Web of Science ®Google Scholar
• Leachman SA, Hickerson RP, Schwartz ME, Bullough EE, Hutcherson SL, Boucher KM, et al. First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther. 2010; 18:442–6.
   PubMed Web of Science ®Google Scholar
• Atkinson SD, McGilligan VE, Liao H, Szeverenyi I, Smith FJ, Moore CB, et al. Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex. J Invest Dermatol. 2011;131:2079–86.
   PubMed Web of Science ®Google Scholar
• Wally V, Klausegger A, Koller U, Lochmuller H, Krause S, Wiche G, et al. 5’ Trans-splicing repair of the PLEC1 gene. J Invest Dermatol. 2008;128:568–74.
   PubMed Web of Science ®Google Scholar
• Dallinger G, Puttaraju M, Mitchell LG, Yancey KB, Yee C, Klausegger A, et al. Development of spliceosome-mediated RNA trans-splicing (SMaRT) for the correction of inherited skin diseases. Exp Dermatol. 2003;12:37–46.
   PubMed Web of Science ®Google Scholar
• Wally V, Brunner M, Lettner T, Wagner M, Koller U, Trost A, et al. K14 mRNA reprogramming for dominant epidermolysis bullosa simplex. Hum Mol Genet. 2010;19:4715–25.
   PubMed Web of Science ®Google Scholar
• Carulli S, Contin R, De Rosa L, Pellegrini G, De Luca M. The long and winding road that leads to a cure for epidermolysis bullosa. Regen Med. 2013;8:467–81.
   PubMedGoogle Scholar
• Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, Recchia A, et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med. 2006;12: 1397–402.
   PubMed Web of Science ®Google Scholar
• Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet. 2010; 11:636–46.
   PubMed Web of Science ®Google Scholar
• Carroll D. Genome engineering with zinc-finger nucleases. Genetics. 2011;188:773–82.
   PubMed Web of Science ®Google Scholar
• Osborn MJ, Starker CG, McElroy AN, Webber BR, Riddle MJ, Xia L, et al. TALEN-based gene correction for epidermolysis bullosa. Mol Ther. 2013;21:1151–9.
   PubMed Web of Science ®Google Scholar
• Remington J, Wang X, Hou Y, Zhou H, Burnett J, Muirhead T, et al. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther. 2009;17:26–33.
   PubMed Web of Science ®Google Scholar
• Woodley DT, Wang X, Amir M, Hwang B, Remington J, Hou Y, et al. Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa. J Invest Dermatol. 2013;133:1910–13.
   PubMed Web of Science ®Google Scholar
• Palazzi X, Marchal T, Chabanne L, Spadafora A, Magnol JP, Meneguzzi G. Inherited dystrophic epidermolysis bullosa in inbred dogs: a spontaneous animal model for somatic gene therapy. J Invest Dermatol. 2000;115:135–7.
   PubMed Web of Science ®Google Scholar
• Cogan J, Wang XY, Hou YP, Khilili M, Woodley DT, Chen M. Epitope mapping of anti-type VII collagen antibodies in the patients with recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2013;133:S45.
   Google Scholar
• Wong T, Gammon L, Liu L, Mellerio JE, Dopping-Hepenstal PJ, Pacy J, et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2008;128:2179–89.
   PubMed Web of Science ®Google Scholar
• Nagy N, Almaani N, Tanaka A, Lai-Cheong JE, Techanukul T, Mellerio JE, et al. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. J Invest Dermatol. 2011;131:1771–4.
   PubMed Web of Science ®Google Scholar
• Fritsch A, Loeckermann S, Kern JS, Braun A, Bosl MR, Bley TA, et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest. 2008;118:1669–79.
   PubMed Web of Science ®Google Scholar
• Kern JS, Loeckermann S, Fritsch A, Hausser I, Roth W, Magin TM, et al. Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol Ther. 2009;17:1605–15.
   PubMed Web of Science ®Google Scholar
• Venugopal SS, Yan W, Frew JW, Cohn HI, Rhodes LM, Tran K, et al. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol. 2013;69:898–908.e7.
   PubMed Web of Science ®Google Scholar
• Petrof G, Martinez-Queipo M, Mellerio JE, Kemp P, McGrath JA. Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomised, vehicle- controlled trial. Br J Dermatol. 2013;169:1025–33.
   PubMed Web of Science ®Google Scholar
• Conget P, Rodriguez F, Kramer S, Allers C, Simon V, Palisson F, et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy. 2010;12:429–31.
   PubMed Web of Science ®Google Scholar
• Tamai K, Yamazaki T, Chino T, Ishii M, Otsuru S, Kikuchi Y, et al. PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc Natl Acad Sci U S A. 2011;108:6609–14.
   PubMed Web of Science ®Google Scholar
• Dimarino AM, Caplan AI, Bonfield TL. Mesenchymal stem cells in tissue repair. Front Immunol. 2013;4:201.
   PubMed Web of Science ®Google Scholar
• Tolar J, Mehta PA, Walters MC. Hematopoietic cell transplantation for nonmalignant disorders. Biol Blood Marrow Transplant. 2012;18: S166–71.
   Google Scholar
• Wagner JE, Ishida-Yamamoto A, McGrath JA, Hordinsky M, Keene DR, Woodley DT, et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med. 2010;363:629–39.
   PubMed Web of Science ®Google Scholar
• Tolar J, Blazar BR, Wagner JE. Concise review: transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa. Stem Cells. 2011;29:900–6.
   PubMedGoogle Scholar
• Tolar J, Wagner JE. Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix. Lancet. 2013;382:1214–23.
   PubMed Web of Science ®Google Scholar
• Jonkman MF, Scheffer H, Stulp R, Pas HH, Nijenhuis M, Heeres K, et al. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell. 1997;88:543–51.
   PubMed Web of Science ®Google Scholar
• Almaani N, Nagy N, Liu L, Dopping-Hepenstal PJ, Lai-Cheong JE, Clements SE, et al. Revertant mosaicism in recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2010;130:1937–40.
   PubMed Web of Science ®Google Scholar
• Lai-Cheong JE, McGrath JA. Revertant mosaicism in the skin. G Ital Dermatol Venereol. 2013;148:73–82.
   PubMedGoogle Scholar
• Pasmooij AM, Nijenhuis M, Brander R, Jonkman MF. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations. J Invest Dermatol. 2012;132:1374–83.
   Google Scholar
• Gostynski A, Deviaene FC, Pasmooij AM, Pas HH, Jonkman MF. Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy. Br J Dermatol. 2009;161:444–7.
   PubMed Web of Science ®Google Scholar
• Gostynski A, Pasmooij AM, Bremer J, Huizinga J, Duipmans J, Jonkman MF. Successful therapeutic transplantation of revertant skin in a patient with epidermolysis bullosa. J Invest Dermatol. 2013; 133:S132.
   Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–72.
   PubMed Web of Science ®Google Scholar
• Hou P, Li Y, Liu C, Guan J, Li H, Zhao T, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science.2013;341:651–4.
   PubMed Web of Science ®Google Scholar
• Tolar J, Xia L, Riddle MJ, Lees CJ, Eide CR, McElmurry RT, et al. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2011;131: 848–56.
   PubMed Web of Science ®Google Scholar
• Itoh M, Kiuru M, Cairo MS, Christiano AM. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2011;108:8797–802.
   PubMed Web of Science ®Google Scholar
• Tolar J, McGrath JA, Xia L, Riddle M, Lees CJ, Eide C, et al. Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2014; in press.
   Google Scholar
• Bidou L, Allamand V, Rousset JP, Namy O. Sense from nonsense: therapies for premature stop codon diseases. Trends Mol Med. 2012;18:679–88.
   PubMed Web of Science ®Google Scholar
• Roberts RG. A read-through drug put through its paces. PLoS Biol. 2013;11:e1001458.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Jiang Q, Takahagi S, Shao C, Uitto J. Premature termination codon read-through in the abcc6 gene: potential treatment for pseudoxanthoma elasticum. J Invest Dermatol. 2013;133:2672–7.
   PubMed Web of Science ®Google Scholar
• Wally V, Kitzmueller S, Lagler F, Moder A, Hitzl W, Wolkersdorfer M, et al. Topical diacerin for epidermolysis bullosa. Orphanet J Rare Dis. 2013;8:69.
   PubMedGoogle Scholar